Skip to content

Research at St Andrews

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

Research output: Contribution to journalArticle

Author(s)

Nadine D Arnold, Josephine A Pickworth, Laura E West, Sarah Dawson, Joana A Carvalho, Helen Casbolt, Adam T Braithwaite, James Iremonger, Lewis Renshall, Volker Germaschewski, Matthew McCourt, Philip Bland-Ward, Hager Kowash, Abdul G Hameed, Alexander M K Rothman, Maria G Frid, A A Roger Thompson, Holly R Evans, Mark Southwood, Nicholas W Morrell & 7 more David C Crossman, Moira K B Whyte, Kurt R Stenmark, Christopher M Newman, David G Kiely, Sheila E Francis, Allan Lawrie

School/Research organisations

Abstract

Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Current treatments increase life expectancy but have limited impact on the progressive pulmonary vascular remodelling that drives PAH. Osteoprotegerin (OPG) is increased within serum and lesions of patients with idiopathic PAH and is a mitogen and migratory stimulus for pulmonary artery smooth muscle cells (PASMCs). Here, we report that the pro-proliferative and migratory phenotype in PASMCs stimulated with OPG is mediated via the Fas receptor and that treatment with a human antibody targeting OPG can attenuate pulmonary vascular remodelling associated with PAH in multiple rodent models of early and late treatment. We also demonstrate that the therapeutic efficacy of the anti-OPG antibody approach in the presence of standard of care vasodilator therapy is mediated by a reduction in pulmonary vascular remodelling. Targeting OPG with a therapeutic antibody is a potential treatment strategy in PAH.

Close

Details

Original languageEnglish
Article number5183
Number of pages18
JournalNature Communications
Volume10
DOIs
Publication statusPublished - 15 Nov 2019

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

    Mullen, M., Jin, X. Y., Child, A., Stuart, A. G., Dodd, M., Aragon-Martin, J. A., Gaze, D., Kiotsekoglou, A., Yuan, L., Hu, J., Foley, C., Van Dyck, L., Knight, R., Clayton, T., Swan, L., Thomson, J. D. R., Erdem, G., Crossman, D., Flather, M. & AIMS Investigators, 21 Dec 2019, In : Lancet. 394, 10216, p. 2263-2270

    Research output: Contribution to journalArticle

  2. Dietary docosahexaenoic acid reduces oscillatory wall shear stress, atherosclerosis and hypertension, most likely mediated via an IL-1-mediated mechanism

    Alfaida, M., Chamberlain, J., Rothman, A., Crossman, D. C., Villa-Uriol, M-C., Hadoke, P., Wu, J., Schenkel, T., Evans, P. & Francis, S., 3 Jul 2018, In : Journal of the American Heart Association. 7, 13, 19 p., e008757.

    Research output: Contribution to journalArticle

  3. ATP evokes Ca2+ responses and CXCL5 secretion via P2X4 receptor activation in human monocyte-derived macrophages

    Layhadi, J. A., Turner, J., Crossman, D. & Fountain, S. J., 1 Feb 2018, In : The Journal of Immunology. 200, 3, p. 1159-1168

    Research output: Contribution to journalArticle

  4. Canakinumab for atherosclerotic disease

    MRC-ILA Heart investigators, Rothman, A. M., Morton, A. C. & Crossman, D. C., 11 Jan 2018, In : New England Journal of Medicine. 378, 2, p. 197-8 2 p.

    Research output: Contribution to journalArticle

Related by journal

  1. A GABAergic Maf-expressing interneuron subset regulates the speed of locomotion in Drosophila

    Babski, H., Jovanic, T., Surel, C., Yoshikawa, S., Zwart, M. F., Valmier, J., Thomas, J. B., Enriquez, J., Carroll, P. & Garcès, A., 22 Oct 2019, In : Nature Communications. 10, 17 p., 4796.

    Research output: Contribution to journalArticle

  2. A family of Type VI secretion system effector proteins that form ion-selective pores

    Mariano, G., Trunk, K., Williams, D. J., Monlezun, L., Strah, H., Pitt, S. J. & Coulthurst, S. J., 2 Dec 2019, In : Nature Communications. 10, p. 1-15 15 p., 5484.

    Research output: Contribution to journalArticle

  3. Allosteric activation of an ion channel triggered by modification of mechanosensitive nano-pockets

    Kapsalis, C., Wang, B., El Mkami, H., Pitt, S. J., Schnell, J., Smith, T. K., Lippiat, J., Bode, B. E. & Pliotas, C., 10 Oct 2019, In : Nature Communications. 10, 14 p., 4619.

    Research output: Contribution to journalArticle

  4. An oxalate cathode for lithium ion batteries with combined cationic and polyanionic redox

    Yao, W., Armstrong, A. R., Zhou, X., Sougrati, M-T., Kidkhunthod, P., Tunmee, S., Sun, C., Sattayaporn, S., Lightfoot, P., Ji, B., Jiang, C., Wu, N., Tang, Y. & Cheng, H-M., 2 Aug 2019, In : Nature Communications. 10, 9 p., 3483.

    Research output: Contribution to journalArticle

Related by journal

  1. Nature Communications (Journal)

    Andy Gardner (Reviewer)
    Feb 2018

    Activity: Publication peer-review and editorial work typesPeer review of manuscripts

ID: 263392099

Top